Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Stefanie Steidl"'
Autor:
Klaus Cichutek, Cheick Coulibaly, Matthias Schweizer, Stefanie Steidl, Silke Schüle, Ulrich Kalinke, Sylvia Panitz
Publikováno v:
Virology. 351(1):237-247
The coreceptor usage of HIV-1 envelope proteins (Env) is mainly dependent on a defined variable region within the V3-loop of Env. Thus, retroviral vectors derived from murine leukemia virus (MLV), which have been pseudotyped with HIV-1 envelope prote
Autor:
Stefanie Steidl, Jörn Stitz, Klaus Boller, Matthias Schweizer, Silke Schüle, Klaus Cichutek, Michael D. Mühlebach
Publikováno v:
Journal of General Virology. 85:665-678
To achieve specific gene transfer into human CD4(+) cells, murine leukaemia virus (MLV)-based pseudotype vector particles were generated employing Env variants derived from human or simian immunodeficiency virus (HIV-1 or SIVagm). Here, we describe t
Autor:
Wolfgang Uckert, Klaus Cichutek, Matthias Schweizer, Stefanie Steidl, Jörn Stitz, Michael D. Mühlebach, Isabel Schmitt, Thomas Blankenstein
Publikováno v:
Journal of Molecular Medicine. 81:801-810
The success of several gene therapeutic approaches requires efficient transduction of human primary T lymphocytes. For this it is important to enhance the transduction efficiency, and this can be achieved by various means, mainly technical developmen
Autor:
Stephen Norley, Silke Holzammer, Renate König, Edgar Holznagel, Cheick Coulibaly, Klaus Cichutek, Egbert Flory, Jeanette Neumann, Stefanie Steidl
Publikováno v:
Journal of Virology. 76:10627-10636
During human immunodeficiency virus type 1 (HIV-1) infection, disease progression correlates with the occurrence of variants using the coreceptor CXCR4 for cell entry. In contrast, apathogenic simian immunodeficiency virus (SIV) from African green mo
Autor:
Renate König, Egbert Flory, Stefanie Steidl, Isabel Schmitt, Jörn Stitz, Klaus Cichutek, Matthias Schweizer
Publikováno v:
Virology. 300:205-216
Retroviral vectors derived from murine leukemia virus (MLV) have been pseudotyped with a variant of the envelope glycoprotein (Env) of nonpathogenic simian immunodeficiency virus from African green monkeys (SIVagm) to result in [MLV(SIVagm-wt)] vecto
Autor:
Stefanie Steidl, Michael D. Mühlebach, M. Scherr, Isabel Schmitt, Renate König, Matthias Schweizer, M. Selbert, U. Blömer, Jörn Stitz, P. Wehner, Klaus Cichutek
Publikováno v:
Virology. 291(2):191-197
The improvement of gene transfer efficiency in growth-arrested cells using human immunodeficiency virus type 1 (HIV-1)-derived vectors led to the development of vectors derived from other members of the lentivirus family. Here we report the generatio
Autor:
Martin Engelstädter, Heike Merget-Millitzer, RA Willemsen, Stefanie Steidl, Maria Bobkova, Klaus Cichutek, Christian J. Buchholz, Jörn Stitz
Publikováno v:
Gene Therapy. 8:1202-1206
In contrast to murine leukaemia virus (MLV)-derived vector systems, vector particles derived from the avian spleen necrosis virus (SNV) have been successfully targeted to subsets of human cells by envelope modification with antibody fragments (scFv).
Autor:
Martin Engelstädter, Renate König, Frank Nocken, Maria Bobkova, Christian J. Buchholz, Jörn Stitz, Peter Müller, Isabel Schmitt, Stefanie Steidl, Heike Merget-Millitzer, Klaus Cichutek, Reinhard Kurth
Publikováno v:
Virology. 267:229-236
Retroviral vectors derived from amphotropic murine leukemia viruses (MLV) mediate gene transfer into almost all human cells and are thus not suitable for in vivo applications in gene therapy in which cell-specific gene delivery is required. We and ot
Autor:
Ulrich Kalinke, Matthias Schweizer, Klaus Cichutek, Sylvia Raupp, Silke Schuele, Stefanie Steidl, Cheick Coulibaly
Publikováno v:
Molecular Therapy. 11:S184-S185
Top of pageAbstract Retroviral vectors derived from murine leukemia virus (MLV) and pseudotyped with the HIV-1 envelope (Env) protein enable specific gene transfer into CD4+ cells and may therefore be suitable for in vivo gene transfer for the treatm
Autor:
Schuele, Silke1, Steidl, Stefanie1, Raupp, Sylvia1, Coulibaly, Cheick1, Kalinke, Ulrich1, Cichutek, Klaus1, Schweizer, Matthias1
Publikováno v:
Molecular Therapy. Jun2005, Vol. 11, p184-185. 2p.